A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
Clinical trial NCT03261037 · COMPLETED
Trial details
- NCT number
- NCT03261037
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-25
- Primary completion
- 2019-11-27
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.